Hello and Welcome to Patientsville.com, Your Source for all OXAZEPAM information. We are dedicated to provide You with OXAZEPAM safety information. Learn about OXAZEPAM serious adverse events reported to Food and Drug Administration (FDA).

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Health Expert

OXAZEPAM Safety Reports

Total OXAZEPAM reports: 12.
OXAZEPAM FDA safety alerts: No.
Reported deaths: 3    Reported hospitalizations: 6.
Take OXAZEPAM Side Effects Survey or Share Your OXAZEPAM Story. Read More Here.

Consumer or non-health professional from DENMARK reported OXAZEPAM problem on Dec 22, 2006. Female patient was treated with OXAZEPAM. After drug was administered, patient experienced the following problems/side effects: chondropathy, congenital acrochordon, congenital anomaly. OXAZEPAM dosage: 15 MG; BID; TRPL. During the same period patient was treated with CLEMASTINE FUMARATE, SERTRALINE. Patient recovered.

OXAZEPAM problem was reported by a Physician from DENMARK on Dec 28, 2006. Female patient, weighting 5.29 lb, was treated with OXAZEPAM. After drug was administered, patient experienced the following problems/side effects: chondropathy, congenital acrochordon. OXAZEPAM dosage: 15 MG, BID, TRANSPLACENTAL. During the same period patient was treated with TAVEGYL, ZOLOFT. Patient recovered.

Physician from DENMARK reported OXAZEPAM problem on Dec 28, 2006. Female patient, weighting 5.29 lb, was treated with OXAZEPAM. After drug was administered, patient experienced the following problems/side effects: chondropathy, congenital acrochordon, congenital musculoskeletal anomaly. OXAZEPAM dosage: 15 MG, BID, TRANSPLACENTAL. During the same period patient was treated with TAVEGYL, ZOLOFT. Patient recovered.

OXAZEPAM problem was reported by a Consumer or non-health professional from on Apr 02, 2007. Female patient, 39 years of age, was treated with OXAZEPAM. OXAZEPAM dosage: unknown. During the same period patient was treated with PARACETAMOL, DIAZEPAM, LORAZEPAM, DIPHENHYDRAMINE, CLONAZEPAM, ATROPINE, TOPIRAMATE, CIPROFLOXACIN. Patient died.

Consumer or non-health professional from reported OXAZEPAM problem on Apr 11, 2007. Female patient, 39 years of age, was treated with OXAZEPAM. OXAZEPAM dosage: unknown. During the same period patient was treated with PARACETAMOL, DIAZEPAM, LORAZEPAM, DIPHENHYDRAMINE, CLONAZEPAM, ATROPINE, TOPIRAMATE, CIPROFLOXACIN. Patient died.

OXAZEPAM problem was reported by a Consumer or non-health professional from ITALY on Sept 01, 2006. Male patient, 50 years of age, weighting 187.4 lb, was treated with OXAZEPAM. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, electrocardiogram qrs complex shortened, hypovolaemia, metabolic acidosis, shock, suicide attempt. OXAZEPAM dosage: unknown. During the same period patient was treated with PROPRANOLOL, HYDROCHLORIC ACID. Patient recovered.

Physician from NETHERLANDS reported OXAZEPAM problem on Dec 14, 2006. Male patient, weighting 160.9 lb, was diagnosed with colorectal cancer and was treated with OXAZEPAM. After drug was administered, patient experienced the following problems/side effects: aortic aneurysm, constipation, haemoglobin decreased, haemorrhage, shock. OXAZEPAM dosage: unknown. During the same period patient was treated with ACETAMINOPHEN, BEVACIZUMAB, CAPECITABINE, OXALIPLATIN. Patient was hospitalized. Patient died on 12/05/2006.

OXAZEPAM problem was reported by a Consumer or non-health professional from on Dec 15, 2006. Female patient, 17 years of age, was treated with OXAZEPAM. After drug was administered, patient experienced the following problems/side effects: heart rate increased, loss of consciousness, metabolic acidosis, mydriasis, psychomotor hyperactivity, pupillary light reflex tests abnormal. OXAZEPAM dosage: unknown. During the same period patient was treated with CITALOPRAM HYDROBROMIDE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from NETHERLANDS reported OXAZEPAM problem on Aug 08, 2007. Male patient, 29 years of age, was treated with OXAZEPAM. After drug was administered, patient experienced the following problems/side effects: agitation, blood creatine phosphokinase increased, blood pressure increased, clonus, depressed level of consciousness, glasgow coma scale abnormal, hypoglycaemia, intentional overdose. OXAZEPAM dosage: unknown. During the same period patient was treated with VENLAFAXINE. Patient was hospitalized. Patient recovered.

OXAZEPAM problem was reported by a Consumer or non-health professional from on Aug 24, 2007. Male patient, 37 years of age, was treated with OXAZEPAM. After drug was administered, patient experienced the following problems/side effects: coma, tachycardia. OXAZEPAM dosage: unknown. During the same period patient was treated with IBUPROFEN, COCAINE, DOXEPIN, CITALOPRAM, TILIDINE, NALOXONE, BUPRENORPHINE, FLUNITRAZEPAM. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from reported OXAZEPAM problem on Aug 24, 2007. Male patient, 55 years of age, was treated with OXAZEPAM. After drug was administered, patient experienced the following problems/side effects: colonic atony, depression, psychotic disorder. OXAZEPAM dosage: unknown. During the same period patient was treated with SERTRALINE, MIRTAZAPINE, DIAZEPAM, FUROSEMIDE, THEOPHYLLINE, ENALAPRIL, LISINOPRIL, RAMIPRIL. Patient was hospitalized. Patient recovered.

OXAZEPAM problem was reported by a Consumer or non-health professional from on Aug 24, 2007. Male patient, 43 years of age, was treated with OXAZEPAM. After drug was administered, patient experienced the following problems/side effects: somnolence. OXAZEPAM dosage: unknown. During the same period patient was treated with DIAZEPAM, DOXEPIN, CLOMETHIAZOLE, METOPROLOL SUCCINATE. Patient was hospitalized. Patient recovered.

back to top

New! Check out useful Hospital Quality Data! Click on a state to continue:

ALABAMA  ALASKA  AMERICAN SAMOA  ARIZONA  ARKANSAS  CALIFORNIA  COLORADO  CONNECTICUT  DELAWARE  DISTRICT OF COLUMBIA  FEDERATED STATES OF MICRONESIA  FLORIDA  GEORGIA  GUAM  HAWAII  IDAHO  ILLINOIS  INDIANA  IOWA  KANSAS  KENTUCKY  LOUISIANA  MAINE  MARSHALL ISLANDS  MARYLAND  MASSACHUSETTS  MICHIGAN  MINNESOTA  MISSISSIPPI  MISSOURI  MONTANA  NEBRASKA  NEVADA  NEW HAMPSHIRE  NEW JERSEY  NEW MEXICO  NEW YORK  NORTH CAROLINA  NORTH DAKOTA  NORTHERN MARIANA ISLANDS  OHIO  OKLAHOMA  OREGON  PALAU  PENNSYLVANIA  PUERTO RICO  RHODE ISLAND  SOUTH CAROLINA  SOUTH DAKOTA  TENNESSEE  TEXAS  UTAH  VERMONT  VIRGIN ISLANDS  VIRGINIA  WASHINGTON  WEST VIRGINIA  WISCONSIN  WYOMING back to top

Home Care Provider Quality Reports and Home Care Provider Reviews

ALABAMA  ALASKA  AMERICAN SAMOA  ARIZONA  ARKANSAS  CALIFORNIA  COLORADO  CONNECTICUT  DELAWARE  DISTRICT OF COLUMBIA  FEDERATED STATES OF MICRONESIA  FLORIDA  GEORGIA  GUAM  HAWAII  IDAHO  ILLINOIS  INDIANA  IOWA  KANSAS  KENTUCKY  LOUISIANA  MAINE  MARSHALL ISLANDS  MARYLAND  MASSACHUSETTS  MICHIGAN  MINNESOTA  MISSISSIPPI  MISSOURI  MONTANA  NEBRASKA  NEVADA  NEW HAMPSHIRE  NEW JERSEY  NEW MEXICO  NEW YORK  NORTH CAROLINA  NORTH DAKOTA  NORTHERN MARIANA ISLANDS  OHIO  OKLAHOMA  OREGON  PALAU  PENNSYLVANIA  PUERTO RICO  RHODE ISLAND  SOUTH CAROLINA  SOUTH DAKOTA  TENNESSEE  TEXAS  UTAH  VERMONT  VIRGIN ISLANDS  VIRGINIA  WASHINGTON  WEST VIRGINIA  WISCONSIN  WYOMING

back to top

Side Effects can be harmful to Your Health! Check adverse reaction reports for these medication and vaccine side effects:

back to top

Search for additional information about OXAZEPAM here:
Thank you for visiting Patientsville.net. Hope you enjoyed finding information on OXAZEPAM and found answers to OXAZEPAM Questions